In late June, WHO’s Emergency Committee determined that the outbreak did not meet the criteria for such a declaration.
But as the virus continues to spread, WHO Director-General Tedros Adhanom Ghebreyesus wants the committee to take up the issue again, based on the latest data around the epidemiology and evolution of the outbreak.
Tedros said Wednesday that he will convene the committee during the week of July 18, or sooner if needed.
“Testing remains a challenge, and it’s highly probable that there are a significant number of cases not being picked up,” he added. “Europe is the current epicenter of the outbreak, recording more than 80% of cases globally.”
Monkeypox, a viral disease, occurs mostly in central and western Africa, where the virus is endemic — but as part of the latest outbreak, the virus has spread to many regions of the world where it is not typically seen.
Cases are also being reported in African countries that previously were not affected by the virus, and in those places where the virus is endemic, record numbers are being recorded, Tedros said Wednesday. WHO teams are following the data closely, he said.
WHO is working with countries and vaccine manufacturers to coordinate sharing of vaccines for monkeypox, which are scarce. The organization is also working with groups to break the stigma around the virus and spread information to help protect people.
Early data on the outbreak has suggested that gay and bisexual men and other men who have sex with men make up a high number of reported cases, leading to concern about stigmatizing the disease and the LGBTQ community.
However, anyone who has been in close contact with someone who has the virus can be at risk.
It can also spread through respiratory secretions during prolonged face-to-face contact or during intimate physical contact, such as kissing, cuddling or sex.
The rash goes through different stages, developing into pustules before healing.
About 41,500 courses of vaccine distributed in US
A course of Jynneos involves two doses four weeks apart.
Vaccine distribution has also been heavily concentrated in California, Illinois and New York, particularly the three largest US cities: New York, Los Angeles and Chicago.
Massachusetts, Hawaii and Colorado also received a large share of the vaccine distribution to date.
Eleven states have not received any monkeypox vaccine, according to the data; none of them has reported any cases to the CDC.
US monkeypox testing ramps up
Efforts are also underway to ramp up testing for the virus in the US.
The commercial laboratory company Labcorp will begin monkeypox testing Wednesday at its largest facility in the United States, doubling the nation’s capacity to test for the virus, according to the US Centers for Disease Control and Prevention.
“The ability of commercial labs to test for monkeypox is a key pillar in our comprehensive strategy to combat this disease,” CDC Director Dr. Rochelle Walensky said Wednesday. “This will not only increase testing capacity but will make it more convenient for providers and patients to access tests by using existing provider-to-lab relationships.”
If someone thinks they could have a monkeypox infection, a provider will have to order a test. “The public will not be able to go to a Labcorp lab and submit a specimen,” the CDC said in its statement.
The CDC’s Laboratory Response Network has been conducting most of the monkeypox-specific testing in the US, but on June 22, the US Department of Health and Human Services announced that monkeypox testing would expand to five commercial labs: Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics and Sonic Healthcare.
The CDC confirmed Wednesday that it had shipped tests to the labs and that their employees have been trained on how to administer the tests. “CDC anticipates additional commercial laboratories will come online and monkeypox testing capacity will continue to increase throughout the month of July.”
CNN’s Deidre McPhillips and Naomi Thomas contributed to this report.